Loading…
OpGen, Inc. entered a definitive agreement to acquire Curetis GmbH, a wholly-owned subsidiary of Curetis N.V., creating a transatlantic diagnostics company. The combined company will be headquartered in Gaithersburg, MD, USA.
“The combination will create a transatlantic, U.S.-headquartered and Nasdaq-listed company with an innovative commercial-stage molecular diagnostics and bioinformatics franchise.”globenewswire.com
Summarized from public sources; check the original articles before acting on it.